Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Everolimus × CNS × Clear all

Phase

Status

Completed 25 Terminated 7 Recruiting 7 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 14 Gastrointestinal 7 Endocrine 6 Genitourinary 5 Tumor-Agnostic 4 Thoracic 2 Sarcoma 2 Other hematologic neoplasm 2 NET 2 Head & Neck 2 Other solid neoplasm 1 Other neoplasm 1 Gynecologic 1 CNS 1

Conditions

Diffuse Intrinsic Pontine Glioma 1

Interventions

Temozolomide 61 Radiotherapy 49 Carboplatin 23 Bevacizumab 19 Radiosurgery 17 Cisplatin 17 Vincristine 16 Etoposide 16 Cyclophosphamide 16 Surgical Procedures, Operative 13 Magnetic Resonance Spectroscopy 13 Chemotherapy, Adjuvant 10 Melphalan 9 Lomustine 9 Radiation 8 Erlotinib Hydrochloride 8 apatinib 7 anlotinib 7 Pemetrexed 7 Filgrastim 7 Drug Therapy 7 3-Iodobenzylguanidine 7 Peripheral Blood Stem Cell Transplantation 6 Irinotecan 6 Carmustine 6 Blood Specimen Collection 6 camrelizumab 5 aumolertinib 5 Thiotepa 5 Neoadjuvant Therapy 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02233049 2018-07-23

BIOMEDE

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Unknown

Diffuse Intrinsic Pontine Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡